Title: microRNA Expression Abnormalities of Pancreatic, Endocrine, and Acinar Tumors
Patent Number: 7,670,840
Filed: Jan. 3, 2007 PCT Filed: Jan. 3, 2007
Lead Inventor: Carlo Croce, Ohio State University
The invention, the patent's abstract states, "provides novel methods and compositions for the diagnosis, prognosis, and treatment of pancreatic cancer. The invention also provides methods of identifying anti-pancreatic cancer agents."